Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01012596 · ClinicalTrials.gov registry record
Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 624
- Enrollment target
NCT01012596: Completed study, sponsored by University of Utah.
NCT01012596 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 624 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01012596 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 624 participants
- Enrollment target
Study Summary
The Creighton Model (CrM) FertilityCare System is a natural family planning method that teaches couples to recognize and chart the signs of fertility and infertility in the woman's cycle and to use that knowledge to either achieve or avoid a pregnancy. The method is natural, safe and effective, and it helps the couple understand their fertility. Trained practitioners at FertilityCare Centers teach the Creighton Model across the country, internationally and long distance. Several FertilityCare Centers and the University of Utah are conducting a study to evaluate the effectiveness of the Creighton Model (CrM) for new and return users wanting to avoid pregnancy. While past studies have shown that the Creighton Model is a highly effective method, this study will use new ways to measure how well it works. This is important because the knowledge gained will improve comparisons between the Creighton Model and other family planning methods. The study will also explore intentions and behaviors of couples to avoid or achieve a pregnancy. The investigators hypothesize that for the CrM the pregnancy rate during perfect use to avoid pregnancy will be about 1% and the behaviorally determined avoiding-related pregnancy rate for the CrM will be about 6%. The investigators will also evaluate the pregnancy rate during "typical use" without a previously stated intention to conceive (in CrM terms, a mixture of avoiding and achieving-related behavior).
Interventions
- BEHAVIORAL Creighton Model System of Natural Family Planning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 624 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-05 |
What the finished NCT01012596 record still lists
NCT01012596 is an observational study that tracks outcomes without assigning an intervention. The registered 624 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Creighton Model System of Natural Family Planning is the first listed.
NCT01012596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01012596 about?
NCT01012596 is a clinical study titled "Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)". The Creighton Model (CrM) FertilityCare System is a natural family planning method that teaches couples to recognize and chart the signs of fertility and infertility in the woman's cycle and to use that knowledge to either achieve or avoid a pregnancy. The method is natural, safe and effective, and ...
What is the current status of trial NCT01012596?
This trial is currently completed. The enrollment target is 624 participants. The study started on 2009-10. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01012596?
The interventions under investigation include: Creighton Model System of Natural Family Planning (BEHAVIORAL).
Who is sponsoring clinical trial NCT01012596?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06406049 · 624 participants · NA
Finishing HIV Project
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia